Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Oncotarget|April 29, 2015
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trialEric Assenat, David Azria, Caroline Mollevi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)Cécile Ortholan, Michel Resbeut, Jean-Michel Hannoun-Levi, et al.
Clinical and Translational Radiation Oncology|December 19, 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancerIngrid Masson, Laurène Larriviere, Marc-André Mahé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2019
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failureMaïlys de Meric de Bellefon, Claire Lemanski, Florence Castan, et al.
International Journal of Cancer|March 19, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancerLaura Bourillon, Céline Bourgier, Nadège Gaborit, et al.
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2013
STROGAR - STrengthening the Reporting Of Genetic Association studies in RadiogenomicsSarah L Kerns, Dirk de Ruysscher, Christian N Andreassen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trialMorgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.
BMC Cancer|April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in FranceNadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.
Oncotarget|September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsGaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.
Pageof 25